Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hypertension
Biotech
Idorsia's Tryvio sale behind schedule, but layoffs on track
Idorsia’s plans to sell its hypertension drug Tryvio have faced a speed bump, even as the biotech plows ahead with around 250 layoffs.
James Waldron
Dec 20, 2024 4:42am
AI spots high blood pressure, diabetes in slow-motion video
Nov 18, 2024 11:30am
FDA clears Omron blood pressure cuff with afib detection
Nov 14, 2024 9:00am
CMS to pay for renal denervation from Medtronic, Recor Medical
Nov 6, 2024 4:45am
Cereno's HDAC inhibitor reduces risks from PAH in phase 2 trial
Sep 30, 2024 9:35am
Roche, Alnylam celebrate second ph. 2 win for blood pressure med
Mar 5, 2024 9:05am
